NueHealth has entered a three-year partnership agreement with GeneNews — a Canadian diagnostic products company — to offer its patients early cancer detection tests.
The Nashville-based pharmaceutical company Cumberland Pharmaceuticals received FDA clearance for a randomized, placebo-controlled Phase II clinical study. The study will investigate Portaban, a treatment the company developed for liver cyrossis patients.
Nicole Bradberry was named the next CEO of Captify Health, a gastroenterology care company that supports physician practices, health plans and health systems with technology-enabled services.
More articles on GI company news:
NueHealth, GeneNews partner to offer patients early CRC detection: 3 notes
FDA clears liver cyrossis drug for Phase II study: 4 notes
Captify Health taps Nicole Bradberry as next CEO: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
